Dr Timothy Yap comments on the challenges in using ctDNA in detecting FGFR fusions and the potential of ctRNA in detecting molecular alterations that can drive therapy and monitor both response and resistance to therapy.
To sign up for our newsletter or print publications, please enter your contact information below.